ID: ALA4543879

Max Phase: Preclinical

Molecular Formula: C11H10N4O

Molecular Weight: 214.23

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Nc1ncccc1C(=O)Nc1ccncc1

Standard InChI:  InChI=1S/C11H10N4O/c12-10-9(2-1-5-14-10)11(16)15-8-3-6-13-7-4-8/h1-7H,(H2,12,14)(H,13,15,16)

Standard InChI Key:  MOSJLIPBRILAKM-UHFFFAOYSA-N

Associated Targets(Human)

Protein kinase C iota 2821 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 214.23Molecular Weight (Monoisotopic): 214.0855AlogP: 1.31#Rotatable Bonds: 2
Polar Surface Area: 80.90Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.82CX LogP: 1.05CX LogD: 1.03
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.79Np Likeness Score: -1.60

References

1. Kwiatkowski J, Baburajendran N, Poulsen A, Liu B, Tee DHY, Wong YX, Poh ZY, Ong EH, Dinie N, Cherian J, Jansson AE, Hill J, Keller TH, Hung AW..  (2019)  Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues.,  10  (3): [PMID:30891133] [10.1021/acsmedchemlett.8b00546]

Source